MRK Financials: Merck & Co Inc AI Analysis



Financials

MRK Financial

Merck & Co Inc

$129.52

3.31%

$4.14

At close: Jul 02, 16:00:00 GMT-4

$129.85

0.25%

$0.33

Post-market: Jul 02, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$125.37

Open

$126.17

Day's Range

$125.99 - $129.85

52 week range

$76.66 - $129.85

Volume

5.2M

Avg.Volume

10.3M

Dividend yield

2.80%

EPS (TTM)

3.55

Market Cap

$320.7B

What is MRK?

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	65,768	16,286	16,400	17,276	15,806	15,529
Revenue Growth (YoY)	3%	5%	5%	4%	-2%	-2%
Cost of Revenue	14,423	2,944	4,239	3,783	3,457	3,383
Gross Profit	51,345	13,342	12,161	13,493	12,349	12,146
Selling, General & Admin	10,844	2,668	2,895	2,633	2,648	2,552
Research & Development	23,801	12,558	3,247	4,001	3,995	3,621
Operating Expenses	34,645	15,226	6,142	6,634	6,643	6,173
Other Non Operating Income (Expenses)	741	164	204	152	221	239
Pretax Income	11,630	-3,534	3,420	6,745	4,999	5,903
Income Tax Expense	2,696	709	458	958	571	818
Net Income	8,935	-4,240	2,963	5,785	4,427	5,079
Net Income Growth	-49%	-183%	-21%	83%	-19%	7%
Shares Outstanding (Diluted)	2,472	2,472	2,486	2,498	2,513	2,531
Shares Change (YoY)	-2%	-2%	-2%	-2%	-1%	-1%
EPS (Diluted)	3.61	-1.72	1.19	2.32	1.76	2.01
EPS Growth	-47%	-186%	-20%	87%	-18%	7%
Free Cash Flow	14,115	2,927	1,824	6,835	2,529	1,172
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	78.06%	81.92%	74.15%	78.1%	78.12%	78.21%
Operating Margin	25.39%	-11.56%	36.7%	39.7%	36.1%	38.46%
Profit Margin	13.58%	-26.03%	18.06%	33.48%	28%	32.7%
Free Cash Flow Margin	21.46%	17.97%	11.12%	39.56%	16%	7.54%
EBITDA	22,951	-372	8,485	8,013	6,825	7,072
EBITDA Margin	34.89%	-2.28%	51.73%	46.38%	43.17%	45.54%
D&A For EBITDA	6,251	1,512	2,466	1,154	1,119	1,099
EBIT	16,700	-1,884	6,019	6,859	5,706	5,973
EBIT Margin	25.39%	-11.56%	36.7%	39.7%	36.1%	38.46%
Effective Tax Rate	23.18%	-20.06%	13.39%	14.2%	11.42%	13.85%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

65,768

16,286

16,400

17,276

15,806

15,529

Revenue Growth (YoY)

-2%

Cost of Revenue

14,423

2,944

4,239

3,783

3,457

3,383

Gross Profit

51,345

13,342

12,161

13,493

12,349

12,146

Selling, General & Admin

10,844

2,668

2,895

2,633

2,648

2,552

Research & Development

23,801

12,558

3,247

4,001

3,995

3,621

Operating Expenses

34,645

15,226

6,142

6,634

6,643

6,173

Other Non Operating Income (Expenses)

741

164

204

152

221

239

Pretax Income

11,630

-3,534

3,420

6,745

4,999

5,903

Income Tax Expense

2,696

709

458

958

571

818

Net Income

8,935

-4,240

2,963

5,785

4,427

5,079

Net Income Growth

-49%

-183%

-21%

83%

-19%

Shares Outstanding (Diluted)

2,472

2,486

2,498

2,513

2,531

Shares Change (YoY)

-2%

-1%

EPS (Diluted)

3.61

-1.72

1.19

2.32

1.76

2.01

EPS Growth

-47%

-186%

-20%

87%

-18%

Free Cash Flow

14,115

2,927

1,824

6,835

2,529

1,172

Free Cash Flow Per Share

Gross Margin

78.06%

81.92%

74.15%

78.1%

78.12%

78.21%

Operating Margin

25.39%

-11.56%

36.7%

39.7%

36.1%

38.46%

Profit Margin

13.58%

-26.03%

18.06%

33.48%

28%

32.7%

Free Cash Flow Margin

21.46%

17.97%

11.12%

39.56%

16%

7.54%

EBITDA

22,951

-372

8,485

8,013

6,825

7,072

EBITDA Margin

34.89%

-2.28%

51.73%

46.38%

43.17%

45.54%

D&A For EBITDA

6,251

1,512

2,466

1,154

1,119

1,099

EBIT

16,700

-1,884

6,019

6,859

5,706

5,973

EBIT Margin

25.39%

-11.56%

36.7%

39.7%

36.1%

38.46%

Effective Tax Rate

23.18%

-20.06%

13.39%

14.2%

11.42%

13.85%

Follow-Up Questions

What are Merck & Co Inc's key financial statements?



According to the latest financial statement (Form-10K), Merck & Co Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for MRK?



Merck & Co Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Merck & Co Inc's revenue broken down by segment or geography?



Merck & Co Inc largest revenue segment is Other, at a revenue of 10,446,000,000 in the most earnings release.For geography, United States is the primary market for Merck & Co Inc, at a revenue of 36,510,000,000.

Is Merck & Co Inc profitable?



no, according to the latest financial statements, Merck & Co Inc has a net loss of $0

Does Merck & Co Inc have any liabilities?



no, Merck & Co Inc has liability of 0

How many outstanding shares for Merck & Co Inc?



Merck & Co Inc has a total outstanding shares of 0

Merck & Co Inc (MRK) Financial

MRK Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is MRK?

Merck & Co Inc (MRK) Financial

MRK Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is MRK?

MRK Income

Follow-Up Questions

What are Merck & Co Inc's key financial statements?

What are the key financial ratios for MRK?

How is Merck & Co Inc's revenue broken down by segment or geography?

Is Merck & Co Inc profitable?

Does Merck & Co Inc have any liabilities?

How many outstanding shares for Merck & Co Inc?